Barriers to Tofersen Therapy for Variant SOD1-Mediated ALS
- PMID: 39373990
- DOI: 10.1001/jamaneurol.2024.3331
Barriers to Tofersen Therapy for Variant SOD1-Mediated ALS
Plain language summary
This Viewpoint advocates for the accelerated adoption of tofersen therapy to treat patients with variant SOD1-mediated amyotrophic lateral sclerosis (ALS) and describes the current barriers to treatment.
LinkOut - more resources
Miscellaneous